Literature DB >> 19784539

Astaxanthin suppresses scavenger receptor expression and matrix metalloproteinase activity in macrophages.

Yoshimi Kishimoto1, Mariko Tani, Harumi Uto-Kondo, Maki Iizuka, Emi Saita, Hirohito Sone, Hideaki Kurata, Kazuo Kondo.   

Abstract

BACKGROUND: Astaxanthin is a red carotenoid pigment which has significant potential for antioxidant activity. The macrophages in atherosclerotic lesions, known as activated macrophages, express scavenger receptors responsible for the clearance of pathogenic lipoproteins. In addition, the expression and secretion of proteolytic enzymes, matrix metalloproteinases (MMPs), and pro-inflammatory cytokines are remarkably promoted in activated macrophages. AIM OF THE STUDY: In this study, we investigated the effects of astaxanthin on the expression of scavenger receptors, MMPs, and pro-inflammatory cytokines in macrophages.
METHODS: THP-1 macrophages were incubated with 5-10 microM astaxanthin for 24 h. The expression levels of scavenger receptors, MMPs, and pro-inflammatory cytokines were determined by Western blot analysis or real-time RT-PCR. The MMP-9 and -2 activities were examined by gelatin zymography and total MMP activity was measured by fluorometry.
RESULTS: We found that astaxanthin remarkably decreased the class A scavenger receptor and CD36 expression in the protein and mRNA levels. Astaxanthin also reduced MMP-1, -2, -3, -9, -12, and -14 activity and expression. The mRNA expression of tumor necrosis factor-alpha, interleukin-1beta, interleukin-6, inducible nitric oxide synthase, and cyclooxygenase-2 were significantly suppressed by astaxanthin. Furthermore, astaxanthin inhibited the phosphorylation of nuclear factor-kappaB.
CONCLUSIONS: These results indicate that astaxanthin has inhibitory effects on macrophage activation, such as scavenger receptors up-regulation, MMPs activation, and pro-inflammatory cytokines secretion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19784539     DOI: 10.1007/s00394-009-0056-4

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   5.614


  42 in total

1.  Acute and chronic administration of disodium disuccinate astaxanthin (Cardax) produces marked cardioprotection in dog hearts.

Authors:  Garrett J Gross; Samuel F Lockwood
Journal:  Mol Cell Biochem       Date:  2005-04       Impact factor: 3.396

Review 2.  Combinatorial signals by inflammatory cytokines and chemokines mediate leukocyte interactions with extracellular matrix.

Authors:  G G Vaday; S Franitza; H Schor; I Hecht; A Brill; L Cahalon; R Hershkoviz; O Lider
Journal:  J Leukoc Biol       Date:  2001-06       Impact factor: 4.962

3.  Efficient radical trapping at the surface and inside the phospholipid membrane is responsible for highly potent antiperoxidative activity of the carotenoid astaxanthin.

Authors:  S Goto; K Kogure; K Abe; Y Kimata; K Kitahama; E Yamashita; H Terada
Journal:  Biochim Biophys Acta       Date:  2001-06-06

4.  Antitumor activity of astaxanthin and its mode of action.

Authors:  H Jyonouchi; S Sun; K Iijima; M D Gross
Journal:  Nutr Cancer       Date:  2000       Impact factor: 2.900

5.  Effects of major dietary antioxidants on inflammatory markers of RAW 264.7 macrophages.

Authors:  Won-Jin Jung; Mi-Kyung Sung
Journal:  Biofactors       Date:  2004       Impact factor: 6.113

6.  A comparison of the anticancer activities of dietary beta-carotene, canthaxanthin and astaxanthin in mice in vivo.

Authors:  B P Chew; J S Park; M W Wong; T S Wong
Journal:  Anticancer Res       Date:  1999 May-Jun       Impact factor: 2.480

7.  Expression of matrix metalloproteinase 9 and its regulators in the unstable coronary atherosclerotic plaque.

Authors:  Fei Chen; Per Eriksson; Göran K Hansson; Istvan Herzfeld; Magareta Klein; Lars-Olof Hansson; Guro Valen
Journal:  Int J Mol Med       Date:  2005-01       Impact factor: 4.101

8.  Expression of class A scavenger receptor is enhanced by high glucose in vitro and under diabetic conditions in vivo: one mechanism for an increased rate of atherosclerosis in diabetes.

Authors:  Kaori Fukuhara-Takaki; Masakazu Sakai; Yu-ichiro Sakamoto; Motohiro Takeya; Seikoh Horiuchi
Journal:  J Biol Chem       Date:  2004-11-19       Impact factor: 5.157

9.  Dykellic acid inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting nuclear factor kappa B transcriptional activity.

Authors:  Ju-Hyung Woo; Jong-Wook Park; Sung-Hee Lee; Young-Ho Kim; In Kyu Lee; Edward Gabrielson; Sang-Han Lee; Ho-Jae Lee; Yung-Hee Kho; Taeg Kyu Kwon
Journal:  Cancer Res       Date:  2003-06-15       Impact factor: 12.701

10.  Macrophage as a target of quercetin glucuronides in human atherosclerotic arteries: implication in the anti-atherosclerotic mechanism of dietary flavonoids.

Authors:  Yoshichika Kawai; Tomomi Nishikawa; Yuko Shiba; Satomi Saito; Kaeko Murota; Noriyuki Shibata; Makio Kobayashi; Masaya Kanayama; Koji Uchida; Junji Terao
Journal:  J Biol Chem       Date:  2008-01-16       Impact factor: 5.157

View more
  25 in total

1.  The dual role of TLR3 in metastatic cell line.

Authors:  Tanja Matijevic; Jasminka Pavelic
Journal:  Clin Exp Metastasis       Date:  2011-07-07       Impact factor: 5.150

2.  Anti-inflammatory action of sulfated glucosamine on cytokine regulation in LPS-activated PMA-differentiated THP-1 macrophages.

Authors:  Jung-Ae Kim; Byul-Nim Ahn; Chang-Suk Kong; Se-Kwon Kim
Journal:  Inflamm Res       Date:  2011-08-30       Impact factor: 4.575

Review 3.  The Putative Role of Astaxanthin in Neuroinflammation Modulation: Mechanisms and Therapeutic Potential.

Authors:  Shuai Wang; Xin Qi
Journal:  Front Pharmacol       Date:  2022-06-24       Impact factor: 5.988

Review 4.  Role of Phytochemicals in Skin Photoprotection via Regulation of Nrf2.

Authors:  Anyamanee Chaiprasongsuk; Uraiwan Panich
Journal:  Front Pharmacol       Date:  2022-05-12       Impact factor: 5.988

5.  Astaxanthin decreases the growth-inhibitory dose of cytarabine and inflammatory response in the acute lymphoblastic leukemia cell line NALM-6.

Authors:  Amirhossein Rastgar; Mahtab Sayadi; Gholamreza Anani-Sarab; Seyed Mehdi Sajjadi
Journal:  Mol Biol Rep       Date:  2022-04-20       Impact factor: 2.742

Review 6.  Lipid profile and glucose changes after supplementation with astaxanthin: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Sorin Ursoniu; Amirhossein Sahebkar; Maria-Corina Serban; Maciej Banach
Journal:  Arch Med Sci       Date:  2015-04-23       Impact factor: 3.318

Review 7.  Dietary intake of carotenoids and their antioxidant and anti-inflammatory effects in cardiovascular care.

Authors:  Marco Matteo Ciccone; Francesca Cortese; Michele Gesualdo; Santa Carbonara; Annapaola Zito; Gabriella Ricci; Francesca De Pascalis; Pietro Scicchitano; Graziano Riccioni
Journal:  Mediators Inflamm       Date:  2013-12-31       Impact factor: 4.711

Review 8.  Potential Anti-Atherosclerotic Properties of Astaxanthin.

Authors:  Yoshimi Kishimoto; Hiroshi Yoshida; Kazuo Kondo
Journal:  Mar Drugs       Date:  2016-02-05       Impact factor: 5.118

9.  Effect of astaxanthin on human sperm capacitation.

Authors:  Gabriella Donà; Ivana Kožuh; Anna Maria Brunati; Alessandra Andrisani; Guido Ambrosini; Guglielmo Bonanni; Eugenio Ragazzi; Decio Armanini; Giulio Clari; Luciana Bordin
Journal:  Mar Drugs       Date:  2013-06-03       Impact factor: 5.118

10.  Terminalia bellirica Extract Inhibits Low-Density Lipoprotein Oxidation and Macrophage Inflammatory Response in Vitro.

Authors:  Miori Tanaka; Yoshimi Kishimoto; Emi Saita; Norie Suzuki-Sugihara; Tomoyasu Kamiya; Chie Taguchi; Kaoruko Iida; Kazuo Kondo
Journal:  Antioxidants (Basel)       Date:  2016-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.